Home Ingredients NMN (Nicotinamide Mononucleotide)
EnergyMetabolic HealthLongevity

NMN (Nicotinamide Mononucleotide)

Evidence Level
Moderate
2 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

NMN (nicotinamide mononucleotide) is a precursor that the body uses to make NAD+, a coenzyme central to energy metabolism and cellular repair whose levels decline with age. This has made NMN a popular longevity supplement, studied for healthy aging, energy, and metabolic support. It is closely related to NR (nicotinamide riboside), another NAD+ precursor, and both aim to raise NAD+ levels. Common doses range from 250 to 500 mg per day. Short-term human studies suggest NMN is generally well tolerated, though long-term data is still emerging and its regulatory status has shifted, so quality and sourcing matter.

Studied Dose 250–500 mg/day (commonly studied); up to 1,200 mg/day in clinical trials
Active Compound Beta-Nicotinamide Mononucleotide (NMN) — stabilized crystalline form

Benefits

NAD+ restoration

NMN is rapidly converted to NAD+ in cells, restoring levels that decline 40–50% between ages 40 and 60. Higher NAD+ supports mitochondrial efficiency, DNA repair, and metabolic signaling.

Supported by Trial 2, Trial 1

Metabolic health

Human trials show NMN supplementation improves insulin sensitivity, reduces liver fat, and improves skeletal muscle insulin signaling — effects mediated through NAD+-dependent SIRT1 activation.

Supported by Trial 1, Trial 2

Muscle function and endurance

RCT in older adults showed NMN improved muscle strength, walking speed, and grip strength over 12 weeks, with effects correlating with blood NAD+ increases.

Supported by Trial 1

Cognitive support

Preclinical studies show NAD+ restoration improves neuronal function, reduces neuroinflammation, and supports DNA repair in brain cells. Human cognitive trial data is emerging.

Supported by Trial 1, Trial 2

Mechanism of action

1

NAD+ biosynthesis via salvage pathway

NMN is phosphorylated by NMN adenylyltransferases (NMNATs) to directly produce NAD+. This bypasses rate-limiting steps in other NAD+ precursor pathways, making NMN one of the most efficient NAD+ boosters.

2

Sirtuin activation

Elevated NAD+ activates sirtuins (SIRT1–7), a family of NAD+-dependent deacetylases that regulate gene expression, mitochondrial biogenesis, inflammation, and stress resistance — key longevity pathways.

3

PARP-1 support for DNA repair

NAD+ is consumed by PARP-1 during DNA repair. Restoring NAD+ ensures adequate substrate for DNA damage repair, reducing genomic instability associated with aging.

Clinical trials

1
NMN for Muscle Function in Older Adults — Clinical Trial

Clinical trial in 42 older adults (65+) receiving 250 mg/day NMN vs placebo for 12 weeks. Outcomes: NAD+ metabolites, grip strength, walking speed, timed chair stand. (GeroScience)

42 older adults aged 65+. 12-week intervention.

NMN increased blood NAD+ metabolites. Improved grip strength, walking speed, timed chair-stand test vs placebo. Note: small trial; first-generation human NMN data; effect sizes modest. NMN's evidence base is much smaller than NR's.

2
Oral NMN Safety and Pharmacokinetics in Healthy Men — First Human Trial

First human clinical trial of oral NMN: single doses of 100, 250, 500 mg in 10 healthy men. Outcomes: blood NAD+ metabolites, vital signs, safety. (Endocr J)

10 healthy men. Acute single-dose PK.

All doses safely increased blood NAD+ metabolites within 2-3 hours. No adverse effects on vital signs or metabolic markers. Established baseline NMN safety. Critical caveat: very small trial (n=10), single dose — not efficacy data, just safety/PK.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated in clinical studies up to 1,200 mg/day
Mild nausea or GI discomfort reported by some users at higher doses
Long-term safety data in humans still accumulating — most trials are 12 weeks or less

Important Drug interactions

No established drug interactions — emerging safety data
Theoretically, may interact with medications metabolized through SIRT1/NAD+ pathways
Consult physician if taking immunosuppressants or chemotherapy agents

More Energy Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Energy
Iron
Iron is an essential mineral best known for its central role in making hemoglobin, the pro…
Hydration
Glucose / Dextrose
Glucose (also called dextrose in its pure crystalline form) is the body's primary fuel sug…

Explore Other Ingredients

Cognitive
Phosphatidylserine
Phosphatidylserine (PS) is a phospholipid concentrated in neuronal cell membranes (10-20%…
Muscle & Recovery
Bromelain
Bromelain is a group of protein-digesting enzymes extracted from pineapple stems, used in…
Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…

Frequently asked questions about NMN (Nicotinamide Mononucleotide)

How much NMN should I take?

Common doses range from 250 to 500 mg per day, with some studies using up to 1,000 mg or more. It is a popular longevity supplement, though optimal long-term dosing is still being researched.

What is NMN used for?

NMN (nicotinamide mononucleotide) is a precursor the body uses to make NAD+, a coenzyme central to energy metabolism and cellular repair that declines with age. It is studied for healthy aging, energy, and metabolic support.

NMN or NR, which is better?

NMN and NR (nicotinamide riboside) are both NAD+ precursors and closely related. NR has more published human trials, while NMN is one step closer to NAD+. Both aim to raise NAD+ levels; the practical difference for most people is small and still being studied.

Is NMN safe?

Short-term human studies suggest NMN is generally well tolerated at common doses. Long-term safety data is still emerging, and its regulatory status has shifted, so quality and sourcing matter. Check with your doctor if pregnant, breastfeeding, or on medication.

What is NMN?

NMN (nicotinamide mononucleotide) is a precursor that the body uses to make NAD+, a coenzyme central to energy metabolism and cellular repair whose levels decline with age. This has made NMN a popular longevity supplement, studied for healthy aging, energy, and metabolic support.

What is the recommended dosage of NMN?

The clinically studied dose is 250–500 mg/day (commonly studied); up to 1,200 mg/day in clinical trials Always follow the product label and check with a healthcare provider for personal advice.

Is NMN safe, and does it have side effects?

For most healthy adults, NMN is well tolerated at studied doses. Reported effects can include: Generally well-tolerated in clinical studies up to 1,200 mg/day Mild nausea or GI discomfort reported by some users at higher doses It may also interact with some medications. NMN is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does NMN interact with any medications?

Possible interactions include: No established drug interactions — emerging safety data Theoretically, may interact with medications metabolized through SIRT1/NAD+ pathways If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for NMN?

NutraSmarts rates the evidence for NMN as Moderate (3 out of 5). It is backed by 2 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Christen S, Redeuil K, Goulet L, Giner MP, Breton I, et al. The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026;8(1):62-73..PubMedUsed to support: Human study showing NAD+ boosters raise circulating NAD levels (NMN is a leading NAD+ precursor).